Endpoints News 2026-01-28 FDA suspends Regenxbio gene therapy trials after patient developed brain tumor
Endpoints News 2026-01-28 HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launch
Endpoints News 2026-01-28 Boehringer Ingelheim takes rare kidney disease drug to Phase 3 despite puzzling mid-stage data
Endpoints News 2026-01-27 CMS picks Lilly’s Trulicity, Gilead's Biktarvy for third round of Medicare negotiations
Endpoints News 2026-01-27 Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma